Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.500,04
1,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC International Stem Cell Corporation (QB) (ISCO) International Stem Cell Corporation (QB) (ISCO) Notizie

ISCO

International Stem Cell (QB) (ISCO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ISCO
DataOraFonteTitoloSimboloCompagnia
13/11/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
08/11/202319:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
27/09/202318:27Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ISCOInternational Stem Cell Corporation (QB)
18/09/202314:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/06/202320:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
16/06/202323:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/05/202322:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
28/04/202322:31Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:ISCOInternational Stem Cell Corporation (QB)
30/03/202322:37Edgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/04/202222:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/06/202000:07Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/05/202019:35Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
14/08/201923:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
29/04/201914:30InvestorsHub NewsWireInternational Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
16/04/201914:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End ResultsUSOTC:ISCOInternational Stem Cell Corporation (QB)
07/03/201912:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/02/201914:30InvestorsHub NewsWireInternational Stem Cell Corporation Publishes Successful Results in Traumatic Brain InjuryUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/01/201914:30InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging BusinessUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/12/201814:30InvestorsHub NewsWireInternational Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment ResearchUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/11/201814:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
05/11/201814:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
30/10/201813:30InvestorsHub NewsWireInternational Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual MeetingUSOTC:ISCOInternational Stem Cell Corporation (QB)
08/10/201814:30InvestorsHub NewsWireInternational Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
02/10/201814:00InvestorsHub NewsWireInternational Stem Cell Corporation Raised Funds Through a Private Placement at Premium to MarketUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/08/201813:00InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic ProgramUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201813:00InvestorsHub NewsWireInternational Stem Cell Corp Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201812:49Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ISCOInternational Stem Cell Corporation (QB)
10/07/201813:00InvestorsHub NewsWireInternational Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical ProductsUSOTC:ISCOInternational Stem Cell Corporation (QB)
11/06/201813:00InvestorsHub NewsWireInternational Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/06/201813:00InvestorsHub NewsWireInternational Stem Cell Corporation to Launch Advanced Joint SupplementUSOTC:ISCOInternational Stem Cell Corporation (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ISCO

La tua Cronologia

EU
CICAZ
Credit Mutuel CIC Home L...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network